Saudi Arabia Health Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Alerts
• Clinical Trials
• Forums

Helmet noninvasive ventilation for COVID-19 patients (Helmet-COVID): statistical analysis plan for a randomized controlled trial
DiscussionWe developed a detailed statistical analysis plan to guide the analysis of the Helmet-COVID trial, which is expected to conclude enrollment in November 2021.Trial registrationClinicalTrials.govNCT04477668. Registered on July 20, 2020 (Source: Trials)
Source: Trials - February 2, 2022 Category: Research Source Type: clinical trials

Prediction of Treatment Efficacy of the Combination of Palbociclib/(Letrozole or Anastrozole) in First Line Metastatic Women With Luminal, HER2 Negative Advanced Breast Cancer, Using Infrared Laser Spectroscopy Analysis on Liquid Biopsies.
Condition:   Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer Intervention:   Drug: Combination of Palbociclib and aromatase inhibitor (Letrozole or Anastrozole) Sponsors:   International Cancer Research Group, United Arab Emirates;   King Saud University Medical City, Riyadh, Saudi Arabia;   Max-Planck-Institut für Quantenoptik (MPQ), and Faculty of Physics at Ludwig-Maximilians-Universität München (LMU), Garching, Germany;   King Abdallah University for Scie nce and Technology (KAUST), Thuwal, Saudi Arabia. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 13, 2022 Category: Research Source Type: clinical trials